Sanofi allies with OpenAI, Formation Bio for AI use in drug development / Photo: Kirill KUDRYAVTSEV - AFP/File
-
Sweden says China blocked prosecutors' probe of ship linked to cut cables
-
Acid complicates search after deadly Brazil bridge collapse
-
Norwegian Haugan dazzles in men's World Cup slalom win
-
Arsenal's Saka out for 'many weeks' with hamstring injury
-
Mali singer Traore child custody case postponed
-
France mourns Mayotte victims amid uncertainy over government
-
UK economy stagnant in third quarter in fresh setback
-
Sweden says China denied request for prosecutors to probe ship linked to cut undersea cables
-
African players in Europe: Salah leads Golden Boot race after brace
-
Global stock markets edge higher as US inflation eases rate fears
-
German far-right AfD to march in city hit by Christmas market attack
-
Ireland centre Henshaw signs IRFU contract extension
-
Bangladesh launches $5bn graft probe into Hasina's family
-
US probes China chip industry on 'anticompetitive' concerns
-
Biden commutes sentences for 37 of 40 federal death row inmates
-
Clock ticks down on France government nomination
-
'Devastated' Australian tennis star Purcell provisionally suspended for doping
-
Mozambique on edge as judges rule on disputed election
-
Mobile cinema brings Tunisians big screen experience
-
Philippines says to acquire US Typhon missile system
-
Honda and Nissan to launch merger talks
-
Police arrest suspect who set woman on fire in New York subway
-
China vows 'cooperation' over ship linked to severed Baltic Sea cables
-
Australian tennis star Purcell provisionally suspended for doping
-
Asian markets track Wall St rally as US inflation eases rate fears
-
Luxury Western goods line Russian stores, three years into sanctions
-
Wallace and Gromit return with comic warning about AI dystopia
-
Philippine military says will acquire US Typhon missile system
-
Afghan bread, the humble centrepiece of every meal
-
Honda and Nissan expected to begin merger talks
-
'Draconian' Vietnam internet law heightens free speech fears
-
Israeli women mobilise against ultra-Orthodox military exemptions
-
Asian markets track Wall St rally as US inflation eases rate worries
-
Tens of thousands protest in Serbian capital over fatal train station accident
-
Trump vows to 'stop transgender lunacy' as a top priority
-
Daniels throws five TDs as Commanders down Eagles, Lions and Vikings win
-
'Who's next?': Misinformation and online threats after US CEO slaying
-
Only 12 trucks delivered food, water in North Gaza Governorate since October: Oxfam
-
BluSky Carbon Announces $1 Million Convertible Debenture Financing
-
Abasca Resources Closes Non-Brokered Private Placement of $3.2 Million
-
Greenlane Appoints Rob Shields as Chief Growth Officer
-
American Resources Corporation's ReElement Technologies Produces Greater than 99.5% Pure Terbium For National Defense Supply Chain
-
Beyond Work Unveils Next-Generation Memory-Augmented AI Agent (MATRIX) for Enterprise Document Intelligence
-
Northern Superior Announces ONGold's Completion of Monument Bay and Domain Projects Acquisition in Manitoba
-
ARIA Cybersecurity Solutions Partners with UFT to Protect Water Treatment Facilities from Dangerous Cyberattacks
-
Clear Start Tax Named 2024 Orange County Register’s Top Workplaces for Exceptional Tax Resolution Service and Workplace Culture
-
Ensysce Biosciences Regains Full Compliance with Nasdaq
-
Tortoise Capital Completes Merger of Tortoise Power and Energy Infrastructure Fund, Inc. (NYSE: TPZ), Tortoise Pipeline & Energy Fund, Inc. (NYSE: TTP), and Tortoise Energy Independence Fund, Inc. (NYSE: NDP) and Conversion to Actively Managed ETF
-
Tortoise Capital Completes Merger of Tortoise Energy Infrastructure Corp. (NYSE: TYG) and Tortoise Midstream Energy Fund, Inc. (NYSE: NTG)
-
Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson's Disease
NYSE - LSE
Sanofi allies with OpenAI, Formation Bio for AI use in drug development
French pharmaceutical company Sanofi announced Tuesday a partnership with ChatGPT-founder OpenAI and US biotech firm Formation Bio to accelerate the use of artificial intelligence in developing drugs.
AI is playing an ever greater role in developing new medicines, as well as identifying new applications for existing drugs.
It can be used for example to find new molecules more quickly and to improve clinical tests by vetting which patients would be most likely to respond to treatments.
By combining their resources, the three companies "can reimagine drug development in the pharma industry," said Benjamine Liu, chief executive of Formation Bio.
Sanofi has in recent years cooperated on AI with biotechnology companies such as Owkin, Exscientia, Insilico Medicine, Amunix Pharmaceuticals, Atomwise and Aqemia.
In a statement, Sanofi said: "The three teams will bring together data, software and tuned models to develop custom, purpose-built solutions across the drug development lifecycle."
"Sanofi will leverage this partnership to provide access to proprietary data to develop AI models as it continues on its path to becoming the first biopharma company powered by AI at scale," it said.
OpenAI "will contribute access to cutting-edge AI capabilities, including the ability to fine-tune models, deep AI expertise and dedicated thought partnership and resources."
P.Santos--AMWN
